BioPharma Resources

Drug Trial Radar · NCT06403501

Efficacy and Safety of Clascoterone Cream 1% in Facial Acne Vulgaris

A Multicenter, Randomized, Double-Blind, Vehicle-Controlled Clinical Study to Evaluate the Efficacy and Safety of Clascoterone Cream 1% in Treatment of Subjects With Facial Acne Vulgaris

Last checked: Nov 19, 2026Latest source record: Jul 9, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 692 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

692

Planned (sponsor's estimate)

Start

May 20, 2024

Primary completion

Oct 2026

Study completion Oct 2026

Sponsor

Sponsor type
Industry
First posted
May 8, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 12 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary objective of this study is to determine the safety and efficacy of clascoterone cream, 1%, versus the vehicle cream applied twice daily for 12 weeks in subjects with facial acne vulgaris.

Conditions

  • Acne Vulgaris

Interventions

  • ClascoteroneDrug

    Clascoterone Cream 1% (Winlevi) is indicated for the topical treatment of acne vulgaris in patients 12 years of age and older.

  • Vehicle creamDrug

    Vehicle cream manufactured to mimic look and feel of Clascoterone Cream 1% but without the active ingredient.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants Achieving Success in Investigator's Global Assessment (IGA)Time frame: Week 12
  2. Change From Baseline in Non-inflammatory Lesion (NIL) CountsTime frame: Week 12
  3. Change From Baseline in Inflammatory Lesion (IL) CountsTime frame: Week 12

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Huashan Hospital, Fudan University

    Shanghai, China · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.